A MULTICENTER ASSESSMENT OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) WHO RECEIVED IMMUNE CHECKPOINT INHIBITOR THERAPY (ICI) WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN)

被引：0
作者：
Gross, Evan
Li, Mingjia
Yin, Ming
Orcutt, Delaney
Hussey, Duncan
Trott, Elliot
Kramer, Joel
Oliva, Kaylee
Gore, John
Schade, George
Lin, Daniel
Tykodi, Scott
Hall, Evan
Thompson, John
Parikh, Anish
Yang, Yuanquan
Collier, Katharine
Miah, Abdul
Mori-Vogt, Sherry
Hinkley, Megan
Mortazavi, Amir
Monk, Paul
Folefac, Edmund
Clinton, Steven
Psutka, Sarah
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-08
引用
收藏
页码：E255 / E255
页数：1
相关论文
共 50 条
[31]   Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC) [J].
Araujo, Daniel Vilarim ;
Malone, Eoghan Ruadh ;
Sacher, Adrian G. ;
Fallah-Rad, Nazanin ;
Sridhar, Srikala S. ;
Hansen, Aaron Richard .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[32]   The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis [J].
Mori, Keiichiro ;
Quhal, Fahad ;
Yanagisawa, Takafumi ;
Katayama, Satoshi ;
Pradere, Benjamin ;
Laukhtina, Ekaterina ;
Rajwa, Pawel ;
Mostafaei, Hadi ;
Motlagh, Reza Sari ;
Kimura, Takahiro ;
Egawa, Shin ;
Bensalah, Karim ;
Karakiewicz, Pierre I. ;
Schmidinger, Manuela ;
Shariat, Shariat F. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
[33]   PROGRESSION-FREE AND OVERALL SURVIVAL OF PATIENTS TREATED WITH PRESURGICAL SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY (CN) IN CLEAR CELL SYNCHRONOUS METASTATIC RENAL CELL CARCINOMA (MRCC) [J].
Bex, Axel ;
Blank, Christian ;
Chowdhury, Simon ;
Nichol, David ;
Peters, John ;
Horenblas, Simon ;
O'Brien, Tim ;
Sarwar, Naveed ;
Haanen, John ;
Powles, Thomas .
JOURNAL OF UROLOGY, 2011, 185 (04) :E709-E710
[34]   Salvage lenvatinib/everolimus (LE) combination therapy after immune checkpoint inhibitor (ICI) and VEGFR tyrosine kinase inhibitor (TKI) for metastatic renal cell carcinoma (mRCC) [J].
Khorasanchi, Adam ;
Kwok, Christopher ;
Psutka, Sarah P. ;
Hinkley, Megan ;
Dason, Shawn ;
Yang, Yuanquan ;
Verschraegen, Claire F. ;
Gross, Evan ;
Orcutt, Delaney ;
Yin, Ming .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[35]   CABOPRE: A phase II study of cabozantinib (cabo) prior cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC) [J].
De Velasco, G. ;
Alonso-Gordoa, T. ;
Rodriguez-Moreno, J. F. ;
Duran, I. ;
Carretero-Gonzalez, A. ;
Martin-Soberon, M. ;
Gutierrez Banos, J. L. ;
Guerrero-Ramos, F. ;
Duenas, M. ;
Castellano Gauna, D. .
ANNALS OF ONCOLOGY, 2021, 32 :S698-S699
[36]   Efficacy of VEGFR-TKI plus immune checkpoint inhibitor (ICI) in metastatic renal cell carcinoma (mRCC) patients with favorable IMDC prognosis. [J].
Ciccarese, Chiara ;
Iacovelli, Roberto ;
Bria, Emilio ;
Schinzari, Giovanni ;
Rossi, Ernesto ;
Astore, Serena ;
Cannella, Maria Antonella ;
D'Angelo, Tatiana ;
Cicala, Carlo Maria ;
Maratta, Maria Grazia ;
Tortora, Giampaolo .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[37]   Association between time-of-day of the immune checkpoint inhibitor (ICI) infusion and disease outcomes among patients with metastatic renal cell carcinoma (mRCC). [J].
Dizman, Nazli ;
Govindarajan, Ameish ;
Zengin, Zeynep Busra ;
Meza, Luis A. ;
Tripathi, Nishita ;
Sayegh, Nicolas ;
Castro, Daniela V. ;
Chan, Elyse H. ;
Lee, Kyle O. ;
Prajapati, Sweta R. ;
Feng, Matthew I. ;
Loo, Vivian ;
Pace, Makala ;
O'brien, Shea ;
Bailey, Erin B. ;
Barragan-Carrillo, Regina ;
Chehrazi-Raffle, Alex ;
Li, Xiaochen ;
Agarwal, Neeraj ;
Pal, Sumanta Monty .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[38]   Novel risk stratification criteria of metastatic renal cell carcinoma (mRCC) patients (pts) treated with immune checkpoint inhibitors (ICI). [J].
Martini, Dylan J. ;
Liu, Yuan ;
Shabto, Julie M. ;
Carthon, Bradley Curtis ;
Russler, Greta ;
Hitron, Elise ;
Caulfield, Sarah ;
Kissick, Haydn ;
Harris, Wayne ;
Kucuk, Omer ;
Master, Viraj A. ;
Bilen, Mehmet Asim .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[39]   Safety and efficacy of retreatment with immune checkpoint inhibitors (ICIs) in patients with metastatic RCC (mRCC) who have previously received an ICI [J].
Ravi, Praful ;
Bakouny, Ziad ;
Flippot, Ronan ;
Braun, David A. ;
Abou Alaiwi, Sarah ;
Wei, Xiao X. ;
McGregor, Bradley Alexander ;
Kilbridge, Kerry L. ;
Choudhury, Atish Dipankar ;
Harshman, Lauren Christine ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[40]   IMPACT OF CYTOREDUCTIVE NEPHRECTOMY ON IMMUNE CHECKPOINT INHIBITOR THERAPY: TREATMENT OUTCOMES OF IMMUNE INHIBITORS COMBINATION THERAPIES FOR METASTATIC RENAL CELL CARCINOMA WITH PRIMARY KIDNEY TUMORS [J].
Takagi, Toshio ;
Yoshida, Kazuhiko ;
Fukuda, Norihiro ;
Ishihara, Hiroki ;
Nakamura, Kazutaka ;
Nemoto, Yuki ;
Mizoguchi, Shinsuke ;
Iizuka, Junpei ;
Kondo, Tsunenori .
JOURNAL OF UROLOGY, 2025, 213 (5S)
12345